Related Experiment Video
Updated: Nov 9, 2025

05:55
Identifying Inhibitors of the HBx-DDB1 Interaction Using a Split Luciferase Assay System
Published on: December 21, 2019
6.9K
Targeting ZNF410 as a potential β-hemoglobinopathy therapy
Laxminath Tumburu1, Swee Lay Thein2
1National Heart, Lung and Blood Institute/NIH, Sickle Cell Branch, Bethesda, MD, USA.
Nature Genetics
|April 16, 2021
Summary
No abstract available in PubMed .

